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Abstract. Autocrine motility factor (AMF) is secreted 
by tumor cells and is capable of stimulating the motil- 
ity of the secreting cells. In addition to being ex- 
pressed on the cell surface, its receptor, AMF-R, is 
found within a Triton X-100 extractable intracellular 
tubular compartment.  AMF-R tubules can be distin- 
guished by double immunofluorescence microscopy 
from endosomes labeled with the transferrin  receptor, 
lysosomes labeled with LAMP-2, and the Golgi ap- 
paratus labeled with/~-COP.  AMF-R can also be sepa- 
rated from a LAMP-2 containing lysosomal fraction 
by differential centrifugation of MDCK cells and is 
found within a  100,000 g  membrane pellet.  By elec- 
tron microscopic immunocytochemistry, AMF-R is 
localized predominantly to smooth vesicular and tubu- 
lar membranous organelles as well as to a  lesser ex- 
tent to the plasma membrane and rough endoplasmic 
reticulum.  AMF-R tubules have a variable diameter of 
50-250 nm and can acquire an elaborate branched 
morphology. By immanofluorescence microscopy, 
AMF-R tubules are clearly distinguished from the cal- 
nexin  labeled rough endoplasmic reticulum and AMF-R 
tubule expression is stable to extended cycloheximide 
treatment.  The AMF-R tubule is therefore not a bio- 
synthetic subcompartment of the endoplasmic reticu- 
lum.  The tubular morphology of the AMF-R tubule is 
modulated by both the actin and microtubule cytoskel- 
etons.  In a similar fashion to that described previously 
for the tubular lysosome and endoplasmic reticulum, 
the linear extension and peripheral cellular orientation 
of the AMF-R tubule are dependent on the integrity of 
the microtubule cytoskeleton. The AMF-R tubule may 
thus form part of a  family of microtubule-associated 
tubular organelles. 
T 
n~ complex traffic of membrane proteins within  the 
cell is determined by specific targeting signals in their 
protein  sequences.  The biosynthetic and intracellular 
trafficking routes of various receptors and proteins traverse 
multiple  organelles  and plasma membrane domains,  how- 
ever differential  efficiency of the signals  and mechanisms 
which regulate protein targeting  can result in the predomi- 
nant expression  of a protein in a particular organelle.  The 
steady state distribution  of some proteins has thereby served 
as a marker to identify and define the relationship  between 
intracellular  organelles.  Markers for the rough endoplasmic 
reticulum include calnexin and BiP (Bole et al., 1986; Degen 
and Williams,  1991; Wada et al., 1991; Hochstenbach et al., 
1992) and the intermediate  compartment and/or cis-Golgi 
network is labeled with p53, p58, and gp74 (Saraste  et al., 
1987; Schweizer  et al.,  1988;  Alcalde et al.,  1994).  The 
Golgi apparatus  can be identified by the presence of man- 
nosidase or E-COP (Moreman and Touster,  1985; Donald- 
son et al.,  1990; Duden et al.,  1991; Serafini et al.,  1991) 
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and the trans-Golgi network (TGN) by TGN38 (Luzio et al., 
1990). In the endocytic pathway, early endosomes and the 
early endosomal recycling compartment can be identified by 
the presence of the transferrin  receptor (Hopkins and Trow- 
bridge,  1983; Yarnashiro et al.,  1984).  The late endosome 
has been defined as a mannose-6-phosphate  receptor positive 
and  LAMP  positive  organelle  while  the  lysosome is  a 
mannose-6-phosphate  receptor negative, LAMP positive or- 
ganelle (Geuze et al., 1988; Griffiths et al., 1988), Other dis- 
tinct  and,  perhaps,  function-specific  endocytic organelles 
have been identified  such as the class I/ compartment in 
antigen-presenting  cells (Peters  et al.,  1991; Amigorena et 
al.,  1994; Tulp et al.,  1994). 
Early endosomes, particularly  the sorting  endosome or 
CURL, exhibit a distinctive morphology with tubular exten- 
sions (Geuze et al.,  1983; Marsh et al.,  1986; Griffiths et 
al., 1989; Duan and Maxfield,  1992) and tubular endosomes 
corresponding to the plasma membrane recycling compart- 
ment can be labeled by endocytosis (Wall et al., 1980; Wil- 
son et al., 1987; Gruenberg et al., 1989; Tooze and HoUins- 
head,  1991). Overexpression  of the  small  GTP-binding 
protein rab4 leads to the accumulation  of endocytosed trans- 
ferrin  in a tubular endosomal recycling  compartment (van 
der Sluijs et al.,  1992).  An extensive  endosomal reticular 
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throughout the cytoplasm of HEp2  cells (Hopkins et al., 
1990).  Surface connected tubules implicated in the special- 
ized endocytosis of B-VLDL have been recently described 
(Myers et al., 1993). Brefeldin A (BFA) t treatment induces 
the formation of  tubular elements connecting the Golgi to the 
endoplasmic reticulum and the TGN to early endosomes 
(Cooper  et  al.,  1990;  Lippincott-Schwartz et  al.,  1991; 
Wood et al.,  1991). Tubulation of the Golgi apparatus has 
been observed in the absence of BFA both in vivo and in vitro 
(Cluett et al.,  1993). 
Elongated tubular  membrane organelles have been  ob- 
served in both fixed tissue and cultured cells (Buckley,  1973; 
Phaire-Washington et al.,  1980;  Oliver,  1983;  Beaudoin et 
al.,  1985;  Robinson et al.,  1986;  Swanson et al.,  1987; 
Heuser, 1989; Luo and Robinson, 1992).  Labeling of these 
tubular structures by either fluid phase endocytosis or cyto- 
chemically for lysosomal enzymes led to their appellation as 
lysosomal compartments. The lysosomal nature of the tubu- 
lar lysosome was confirmed by the presence of the lysosomal 
membrane glycoprotein, lgp120, and shown to be associated 
with phagosomes and macropinosomes (Knapp and Swan- 
son, 1990; Racoosin and Swanson, 1993). The morphology 
and cellular distribution of tubular lysosomes are microtubule 
dependent (Phaire-Washington et al., 1980; Swanson et al., 
1987; Araki et al.,  1993).  A macrophage tubular compart- 
ment, continuous with phagolysosomes, exhibits similarities 
with tubular lysosomes and contains both the late endosome 
markers, M6PR and rab7, as well as lysosomal Lamp-2 sug- 
gesting that this tubular organelle is associated with a late en- 
docytic compartment (Rabinowitz et al.,  1992).  The endo- 
plasmic reticulum can also exhibit a highly tubular structure 
throughout the cytoplasm (Fawcett,  1981). Labeling of the 
endoplasmic reticulum in living cells with the dye DiOC6 re- 
veals the extension and formation of an interconnected net- 
work of tubular elements (Terasaki et al.,  1986;  Lee and 
Chen, 1988; Lee et al., 1989). A similar tubular network is 
formed after the in vitro incubation of microsomes on a mi- 
crotubule substrate (Dabora and Sheetz,  1988b;  Vale and 
Hotani, 1988). While tubular organelles have been identified 
morphologically and labeled by endocytic tracers and pro- 
tein markers of other endocytic organelles, a tubule-specific 
protein has yet to be identified. 
The receptor for autocrine motility factor (AMF-R) was 
initially identified by its increased O-glycosylation after cell 
shape  modulation of the  metastatic capability of BI6-FI 
melanoma cells (Nabi  and Raz,  1987, 1988).  Antibodies 
against AMF-R are capable of stimulating both in vivo lung 
colonizing ability and in vitro cell motility (Nabi and Raz, 
1987; Nabi et al., 1990; Watanabe et al., 1991a) leading to 
the identification of AMF-R as the receptor for AMF (Liotta 
et al., 1986; Silletti et al., 1991; Watanabe et al., 1991b). In- 
creased expression of AMF-R correlates directly with the 
loss of E-cadherin in malignant bladder carcinomas and with 
a  high incidence of recurrence and decreased survival in 
colorectal cancer (Nakamori et al., 1994; Otto et al., 1994). 
The AMF-R-mediated signaling pathway by which AMF 
1. Abbreviations used in this  paper: AMF-R, receptor for autocrine motility 
factor; BFA, brefeldin A. 
stimulates cell motility involves a pertussis toxin sensitive 
G-protein,  AMF-R  phosphorylation,  inositol  phosphate 
production, and the lipoxygenase metabolite  12(S)-HETE 
(Stracke et al.,  1987; Kohn et al., 1990; Nabi et al.,  1990; 
Watanabe et al., 1991b; Timar et al., 1993). AMF-R exhibits 
a  polarized cell  surface distribution but intracellularly is 
found within elongated tubular vesicles (Nabi et al., 1992). 
We present evidence here that AMF-R is a marker for a dis- 
tinct membranous tubular organelle. 
Materials and Methods 
Cells and Cell Culture 
All cells were grown in an air-5%  CO2 incubator  at constant  humidity. 
MDCK II cells were grown in DMEM supplemented with 5% FCS, nones- 
sential amino acids, vitamins, and glutamine (Gibco, Burlington, Ontario). 
The MDCK cells used exhibit a highly spread morphology when plated at 
low density at low passage number (<10). HeLa cells were obtained from 
Dr.  Eric  Cohen  (Universit6 de Montr6al,  Montreal,  Quebec) and  were 
grown in DMEM supplemented with 10% FCS, nonessential amino acids, 
glutamine, and a penicillin-streptomycin antibiotic mixture (Gibco). 
Antibodies and Chemicals 
Monoclonal antibody against AMF-R was used either in the form of ascites 
fluid or concentrated hybridoma supernatant (Nabi et al., 1990). Antibod- 
ies to MDCK LAMP-2 were as previously described (Nabi et al., 1991). 
Antibodies to B-COP were kindly provided by Jennifer Lippincott-Schwartz 
(NIH, Bethesda, MD) and to calnexin by John Bergeron (McGill Univer- 
sity,  Montreal,  Quebec).  Antibody  to  the  human  transfcrrin  receptor 
(OKT9) was purchased from Ortho Diagnostics (Raritan, NJ) and to tubulin 
from ICN (Mississauga, Ontario). 
Secondary antibodies  conjugated to either  fluoresc¢in, Texas red,  or 
horseradish peroxidase were purchased from Jackson Laboratories  (West 
Grove, PA). The fluorescent antibodies were designated for use in multiple 
labeling studies and no interspecies cross-reactivity was detected. To detect 
antibodies to AMF-R, secondary antibodies specific for the ~ chain of rat 
IgM were used. Taxol was obtained from the National Products Branch of 
the National Cancer  Institute (Bethesda, MD).  Phalloidin conjugated to 
rhodamine was purchased from Molecular Probes (Eugene, OR). Except 
where otherwise indicated, all chemicals were purchased from ICN Bio- 
medicals, Inc. (Costa Mesa,  CA). 
Immunofluorescence 
Cells were plated sparsely on glass coverslips for 1-2 d, and then fixed by 
the addition of cold (-80°C) methanol directly to the coverslip, and then 
placed at  -20°C for  15 min. In some experiments, cells were incubated 
with Ringer's solution (155 mM NaCI, 5 mM KCI, 2 mM CaCI2, 1 mM 
MgCI2,  2  mM  NaH2PO4,  10  mM  glucose,  10  mM  Hepes,  pH  7.2) 
(Heuser, 1989) for 15 rain at 37°C in a CO2-free incubator, before metha- 
nol fixation. After fixation, cells were rinsed extensively with PBS (pH 7.4) 
supplemented with 0.1 mM Ca  ++ and 1 mM Mg  ++ (PBS/CM), and then in- 
cubated for "-30 min with PBS/CM containing  1% BSA (PBS/CM/BSA) 
to reduce nonspecific binding. All washings and incubations with both pri- 
mary and secondary (FITC and Texas red conjugated) antibodies were done 
with PBS/CM/BSA. After labeling, the coverslips were mounted in Airvol 
(Air Products and Chemicals Inc., Allentown, PA) and viewed in a Zeiss 
Axiophot fluorescent microscope equipped with a 63 ×  Plan Apochromat 
objective  and  selective filters.  Images were  photographed  using Kodak 
T-Max 400 film. 
Immunoblot 
Cell  lysates were separated by SDS-PAGE and blotted to nitrocellulose 
using a Mini-Protean apparatus (BioRad Labs, Hercules, CA). The blots 
were blocked with 20% skim milk in PBS/CM, incubated with the primary 
antibody, and then with the appropriate secondary antibody conjugated to 
horseradish peroxidase. The labeled bands were revealed by chemilumines- 
cence using the ECL system (Amcrsham, Oakville, Ontario), and then ex- 
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markers were purchased from Sigma Chem. Co. (St.  Louis, MO). 
Triton X-IO0 Extraction 
MDCK cells grown on either glass coverslips or tissue culture dishes were 
extracted with 1% Triton X-IO0 in PBS/CM containing protease inhibitors 
(1 mM PMSF, 10 t~g/mi leupeptin, pepstatin A, and aprotinin) at 40C for 
30 min. Cells on coverslips were then fixed with cold methanol and im- 
munofluorescently labeled with anti-AMF-R antibodies. The Triton X-100 
extract of  cells plated on tissue culture dishes was collected and the cellular 
material remaining attached to the plastic surface scraped into an equivalent 
volume of 1% SDS in PBS containing protease inhibitors. The total cellular 
content of AMF-R was determined by the lysis of unextracted cells with 1% 
SDS. Equal amounts by volume of the three lysates, diluted with sample 
buffer,  were  separated  by  SDS-PAGE,  and  blotted  with  antibodies to 
AMF-R. 
Cell Homogenization 
Ten 150-ram plates of MDCK cells, plated at a density of 2  ×  106 cells per 
plate for 2-3 d until the cells were just confluent, were washed 4x  with 
cold PBS, and then left on ice for 10 rain before scraping the cells from the 
tissue culture dish. The scraped ceils were then spun down at 1,500 rpm, 
resuspended in a homogenization buffer consisting of MEPS buffer (5 mM 
MgSO4, 5 mM EGTA, 35 mM K+Pipes, 0.2 M sucrose, pH 7.1) containing 
1 mM DTT and protease inhihitors (Dabora and Sheetz,  1988a),  recen- 
trifuged, and then resuspended in approximately twice the cell volume of 
the homogenization buffer.  The cells were homogenized by 12 strokes of a 
l-ml Dounce homogenizer (fight pestle) on ice, and then centrifuged at 800 g 
at 4"C for 10 min. The pellet was resuspended in half the original volume 
of homogenization buffer,  rehomogenized (12 strokes), and centrifuged at 
800 g.  The two supernatants were combined and centrifuged at 950 g to 
generate a  postnuclear supernatant (PNS).  The PNS was centrifuged at 
20,000 g  for 30 rain (Biofuge 17) and the 20,OO0-g supernatant spun at 
100,000  g  for 60 min (RC M120; Sorvall Instruments, Wilmington, DE; 
fixed angle rotor) at 4°C. Proteins contained within the 1OO,  OO0-g superna- 
tant were precipitated with acetone at -20*C for 30 rain and the 20,0OO-g 
pellet (20K P), the IOO,000-g pellet (100K P), and acetone precipitate of the 
100,OO0-g supernatant (100K S) were resuspended in 1OO #1 of a solution 
of 1% SDS, 50 mM Tris, pH 8, containing protease inhibitors. The samples 
were assayed for protein content using the BCA protein assay (Pierce, Rock- 
ford, IL). Equivalent amounts by volume of each of the samples (between 
40 and 50 #g protein) were separated by SDS-PAGE and blotted with anti- 
bodies to AMF-R and LAMP-2. 
Electron Microscopy 
Cells grown on petri dishes were rinsed and incubated at 37°C in Ringers 
solution for 15 rain before fixing in Ringer's solution containing 2 % parafor- 
maldehyde and 0.2%  glutaraldehyde for 30 rain at 37°C. The fixed cells 
were rinsed in PBS/CM, scraped from the petri dish, and collected by cen- 
trifogation. The cell pellet was posttixed for 30 rain with 1% osmium tetrox- 
ide in PBS/CM containing 1.5 % potassium ferrocyanide (reduced osmium), 
dehydrated in a  graded ethanol series and embedded in LR-White resin 
(Tamaki and Yamashina, 1994).  Ultrathin sections (80 nm) were collected 
on formvar-coated grids, blocked for 1 h with 2 % BSA and 2 % goat serum 
in PBS/CM, and then incubated in PBS/CM/BSA at room temperature for 
1 h with anti-AMF-R antibody followed by 12-nm gold conjugated anti-rat 
IgM (Jackson). The grids were washed with PBS/CM/BSA three times after 
the primary antibody, five times after the secondary antibody, and then 
washed three times with PBS/CM and twice with distilled water. The sec- 
tions were then stained with 5% uranyl acetate for 15 rain and visualized 
in a Philips 300 electron microscope. 
Fields selected morphologically for the presence of a smooth tubule were 
photographed and the numerical density of particles associated with smooth 
tubules and vesicles, the rough endoplasmic reticulum, the plasma mem- 
brane, and the Golgi apparatus determined. The length of  the limiting mem- 
brane of the indicated organelles was measured using a Sigma-Scan mea- 
surement  system  (Jandel  Scientific,  Corte  Madera,  CA)  and  the  gold 
particles localized to these organdies counted. Rough endoplasmic reticu- 
lum was defined by the presence of a linear array of membrane-associated 
ribosomes. The Golgi apparatus was identified morphologically and the 
membrane length of associated saccules and vesicles measured. Control 
labeling was performed with  10  #g/ml  nonimmune rat  IgM  antibodies 
(ICN), at a dilution equivalent to that of anti-AMF-R as determined by dot 
blot, and was analyzed similarly. 
Drug Treatment 
Brefeldin A (Calbiochem, San Diego, CA) was added at a concentration of 
10 #g/ml directly to the cell culture medium for 30 rain. Protein synthesis 
was inhibited by the addition of medium containing 1OO t~g/ml cyclohexi- 
mide to the cells for the indicated time. Cycloheximide treatment reduced 
protein synthesis, measured by TCA precipitation of Triton X-100 extracts 
of [35S]methionine-labeled  cells, to 5 % of the level of untreated cells after 
1.5 h and to 2% after 14 h. 
Actin cytoskeleton disruption was performed by the addition of  0.5 #g/ml 
cytochalasin D to the regular medium for 2 h at 37°C. Micmtubule disrup- 
tion was performed by the addition of 20 #M nocodazole in Ringer's solu- 
tion for 30 rain on ice to cells preincubated for 15 rain with Ringer's solution 
at 4°C. Subsequent incubation with nocadozole or 10 ~M taxol at 37°C for 
30 min was preceded by a rapid rinse with warm Ringer's solution. 
Results 
Tubular Localization of  AMF-R 
The MDCK II ceils used in this study exhibit a highly spread 
morphology at low passage which facilitated visualization of 
AMF-R  distribution  by  fluorescence  microscopy.  Immu- 
nofluorescent  labeling  of MDCK  cells  with  anti-AMF-R 
antibodies after direct fixation with cold methanol shows that 
AMF-R is localized to tubular and vesicular structures  dis- 
tributed throughout the cytoplasm. In some cells, the AMF-R 
labeling  is  localized  to  a  dense  perinuclear  region.  The 
tubular vesicles extend to and are oriented towards  the pe- 
riphery of the cell. A  highly punctate nuclear label is also 
observed in certain cell preparations labeled immunofluores- 
cently with the anti-AMF-R  mAb (Fig.  1 a).  The nuclear 
staining  is  not  always observed  suggesting  that  it is non- 
specific. 
To ascertain the specificity of the nuclear label detected by 
immunofluorescence,  cells were extracted  with  1%  Triton 
X-100 at 4°C, and then fixed with cold methanol for immu- 
nofluorescent labeling.  After Triton  X-100 extraction only 
the punctate nuclear label could be detected and the cyto- 
plasmic tubular label had disappeared  (Fig.  1 b). From par- 
allel cultures, the Triton X-100 extract was collected and the 
petri dishes then scraped and the nonextracted material lysed 
in an equal volume of 1% SDS. AMF-R content of equivalent 
amounts by volume of these fractions was determined by im- 
munoblot and compared to the  total  cellular AMF-R  ex- 
tracted  with SDS (Fig.  1 c).  All AMF-R detected was as- 
sociated  with the  Triton  X-100  extracted  material and  no 
AMF-R could be detected in the nuclear-associated mate- 
rial.  The immunofluorescent nuclear labeling by the anti- 
AMF-R  antibody  is  therefore nonspecific  and  AMF-R  is 
present within a cytoplasmic  Triton X-100  extractable  or- 
ganelle. 
AMF-R Tubules Do Not Colocalize with Early 
Endosomes, Golgi Apparatus,  or Lysosomes 
Tubular  early  endosomes have  been described as have  tu- 
bular  elements  of the  endosomal  recycling  compartment 
(Marsh et al., 1986;  Gruenberg et al., 1989;  Hopkins et al., 
1990; Tooze and Hollinshead,  1991).  Brefeldin A treatment 
induces the formation of elongated tubules between early en- 
dosomes  and the  TGN  (Lippincott-Schwartz  et al.,  1991; 
Wood et al.,  1991).  To assess whether AMF-R is localized 
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to  Triton  3[-100 extractable 
tubules.  MDCK  cells  were 
fixed  with  cold  methanol 
directly (a) or after extraction 
with 1% Triton X-100 for 30 
rain at 4°C (b), and then im- 
munofluorescently labeled for 
AMF-R. After treatment with 
Triton X-IO0, AMF-R tubules 
are extracted but the fluores- 
cent nuclear label remains. In 
c, equal amounts of the total 
cellular extract (Total), Triton 
X-IO0 extracted material (TX- 
100)  and  the  nonextracted 
material (Non-Extr.) were im- 
munobloued  with  antibodies 
to AMF-R (78 kD). Molecu- 
lar mass markers from top to 
bottom:  180, t16, 84, 58, and 
46 kD  Bar, 20 #m. 
to  early endosomes  or  to  early endosome derived BFA- 
induced tubules, HeLa cells were double labeled with anti- 
bodies to AMF-R and the human transferrin receptor (Fig. 
2). In HeLa cells, the transferrin receptor exhibited a charac- 
teristic  punctate  early  endosomal  distribution  throughout 
the cytoplasm. After BFA treatment, elongated tubules were 
formed which localized primarily over the celt nucleus (Fig. 
2 d). AMF-R tubules did not colocalize with the transferrin 
receptor neither before nor after BFA treatment. The BFA- 
induced tubules labeled with the transferrin receptor were 
narrower and more elongated than AMF-R tubules and did 
not extend to the cell periphery as did AMF-R tubules. In 
both HeLa (Fig. 2) and MDCK cells (not shown), the mor- 
phology and distribution of AMF-R tubules were apparently 
unaffected by treatment with BFA. 
Previous studies have described tubular lysosomes labeled 
by fluid phase uptake (Swanson et al., 1987; Heuser, 1989). 
The perinuclear distribution of AMF-R might coincide with 
the Golgi apparatus. To determine whether AMF-R tubules 
colocalize with lysosomes or the Golgi apparatus,  we used 
the organdie specific markers B-COP for the Golgi appara- 
tus  (Donaldson et al.,  1990)  and  LAMP-2  for lysosomes 
(Nabi et al.,  1991; Nabi and Rodriguez-Boulan, 1993). The 
tubular pattern of AMF-R labeling is clearly distinct from 
that of the Golgi apparatus (Fig.  3, a  and b) or lysosomes 
(Fig. 3, c and d). The perinuclear Golgi label does not coin- 
cide with perinuclear AMF-R labeling. In the spread cyto- 
plasmic region of the cells, overlap of AMF-R tubules with 
LAMP-2-1abeled lysosomes is not observed. The AMF-R 
tubule is therefore not equivalent to either the Golgi appara- 
tus or the lysosome. 
Confirmation that AMF-R is not found within LAMP-2- 
containing lysosomes in  MDCK  cells was  obtained from 
subcellular fractionation studies (Fig. 4). MDCK cells grown 
to near confluency yet still spread were scraped from tissue 
culture plates and homogenized. The postnuclear supema- 
tam was centrifuged initially at 20,000 g  and the 20,000-g 
supernatant was then centrifuged at greater than 100,000 g. 
The 20,000-g pellet (20K P), 100,000-g pellet (100K P), and 
100,000-g supernatant (100K S) were analyzed for expres- 
sion of LAMP-2 and AMF-R by immunoblot. LAMP-2 was 
localized predominantly to the 20,000-g lysosornal pellet and 
essentially no LAMP-2 was found in either the  100,000-g 
pellet or supernatant consistent with its lysosomal localiza- 
tion. AMF-R was localized to the 100,000-g pellet consistent 
with its presence in membranous components of the cell. 
The ability to distinguish AMF-R expression from LAMP-2 
by both double immunofluorescence and subcellular frac- 
tionation indicates that, at least in MDCK ceils, the AMF-R 
tubule cannot be considered to be a lysosomal organeUe. 
Electron Microscopic Localization of  AMF-R 
to a Membranous Tubular Compartment 
The lability of the AMF-R tubule to conventional fixatives 
led us to use a rapid cold methanol (-80°C) fixation method 
which  maintains  tubule  morphology  for  immunofluores- 
cence microscopy. Tubular lysosomes have been described 
as  a  highly  labile  organelle  (Robinson  et al.,  1986)  and 
Ringer's solution, a bicarbonate free buffer, has been used 
to study tubular lysosome expression (Heuser, 1989; Racoo- 
sin and Swanson,  1993). Our previous use of this solution 
to study AMF-R tubules (Nabi et al.,  1992) directed us to 
establish a tubule fixation protocol for electron microscopy 
The Journal of Cell Biology,  Volume 129, 1995  462 Figure 2.  AMF-R tubules do not codistribute with endosomes containing the transferrin receptor. HeLa cells were either left untreated 
(a and b) or treated with 10/~g/ml BFA for 60 min (c and d). AMF-R (a and c) and the human transferrin receptor (b and d) were localized 
by double immunofluorescent labeling in the same cells using selective filters. Bar, 20/zm. 
Figure 3. AMF-R tubules do not colocalize  with the Golgi apparatus or lysosomes. MDCK cells were double immunofluorescently labeled 
for AMF-R (a and c) and either/3-COP (b) or LAMP-2 (d). The left and right panels represent identical fields. Bar, 20/zm. 
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also found on rough endoplasmic reticulum defined by the 
presence  of a  linear array  of membrane-associated ribo- 
somes (see Fig. 5, c [top] and d). The significant AMF-R ex- 
pression on the plasma membrane is consistent with the sur- 
face expression of AMF-R and its function as a  motility 
factor receptor (Nabi et al., 1990; Silletti et al., 1991; Nabi 
et al.,  1992).  AMF-R labeling of the Golgi apparatus was 
minimal and essentially equivalent to the labeling detected 
with control nonimmune rat IgM antibody. 
Figure 4. Localization  of AMF-R and LAMP-2 to different subcel- 
lular fractions of  MDCK cells. MDCK cells were homogenized  and 
the postnuclear supematant centrifuged sequentially at 20,000 g 
and 100,000 g to generate a 20,000-g pellet (20K  P), a 100,000-g 
pellet (IOOKP), and a 100,000-g supematant (lOOKS). These frac- 
tions were separated by SDS-PAGE and blotted with antibodies to 
LAMP-2 and AMF-R, as indicated. Molecular mass markers from 
top to bottom: 180, 116, 84, 58, and 46 kD. 
using aldehyde fixatives based on Ringer's solution. MDCK 
cells were rinsed in Ringer's solution, and then fixed with 2 % 
paraformaldehyde  and 0.2 % glutaraldehyde in Ringer's solu- 
tion, and then processed and embedded in the hydrophilic 
LR-White  resin.  AMF-R  labeling  was  weak  but  highly 
specific  for membranous organelles. 
Postembedding  labeling  with  anti-AMF-R  and  12-nm 
gold-conjugated anti-rat secondary antibodies revealed the 
specific cytoplasmic localization of AMF-R to  a  smooth 
membrane limited tubular organeUe  (Fig.  5).  AMF-R la- 
beled both isolated tubules (Fig. 5, c, d, and e) and vesicles 
(Fig. 5, fand g) as well as more elaborate tubular networks 
(Fig. 5, a and b). The average outside diameter of both the 
vesicular and tubular AMF-R-labeled compartments is vari- 
able and ranges from 50-250 nm. Quantification  of  the label- 
ing by morphometry revealed that the majority of AMF-R 
labeling is found on smooth membranous tubules and vesi- 
AMF-R Tubules Do Not Colocalize with the ER 
To better define the relationship of the AMF-R tubule to 
the rough endoplasmic reticulum, we performed double im- 
munofluorescent labeling of AMF-R tubules with the rough 
endoplasmic reticulum marker calnexin (Wada et all., 1991). 
Calnexin has been localized by electron microscopy exclu- 
sively to  the  nuclear  membrane  and  rough  endoplasmic 
reticulum (Hochstenbach et al.,  1992).  MDCK cells pre- 
treated with Ringer's solution before fixation revealed the 
distribution of calnexin to  an extended reticular network 
throughout the cytoplasm. Distinct tubular structures were 
not observed and the distribution of AMF-R-labeled tubules 
could clearly be distinguished from the more diffuse labeling 
of the rough endoplasmic reticulum with calnexin (Fig. 6, a 
and b).  On rare  occasions, AMF-R tubules could be ob- 
served to coincide with calnexin labeling (Fig. 6, a  and b, 
arrows), consistent with the presence of  AMF-R in rough en- 
doplasmic reticulum observed by electron microscopy. To 
ensure that the AMF-R tubule is not a transient subcompart- 
ment of the endoplasmic reticulum in the biosynthetic path- 
way of  AMF-R, we immunolabeled cells after cycloheximide 
treatment (Fig. 6, c and d). The tubular label of AMF-R was 
conserved even after  14 h  of cycloheximide treatment.  In 
contrast, the reticular nature of the endoplasmic reticulum 
was lost and calnexin was distributed diffusely throughout 
the cytoplasm. Under these conditions less than 2 % of the 
protein synthesis of untreated cells could be detected. The 
continued tubular expression of AMF-R after cycloheximide 
treatment demonstrates that AMF-R is a stable component 
of this tubular organelle and that the tubular expression of 
AMF-R is  not due to the presence of newly synthesized 
AMF-R in tubules of the endoplasmic reticulum. The ability 
Table L  Quantitative Analysis  of Postembedding  Labeling  of AMF-R 
Rough 
Smooth tubules  endoplasmic  Plasma  Golgi 
and vesicles  reticulum  membrane  apparatus 
AMF-R 
t~m membrane  344.7  61.2  148.2  24.2 
Gold particles/#m  1.67  4-  0.20  0.58  4- 0.18  0.52  4- 0.13  0.17  4-  0.10 
membrane 
Control 
/~m membrane  78.7  32.0  57.6  47.5 
Gold particles/#m  0.14  4- 0.06  0.02  4- 0.02  0.11  +  0.07  0.27  4- 0.10 
membrane 
Gold panicles associated with the indicated membrane organelles were counted and the density per #m membrane length determined. Control labeling was deter- 
mined using a nonimmune rat IgM antibody. 
The Journal of Cell Biology, Volume 129,  1995  464 Figure 5.  Electron microscopic localization of AMF-R. MDCK cells were fixed with 2 % paraformaldehyde and 0.2 % glutaraldehyde in 
Ringer's solution, osmicated, and embedded in LR white resin before postembedding labeling with anti-AMF-R  and 12-nm gold-conjugated 
anti-rat IgM secondary antibodies. AMF-R is localized to smooth tubules which exhibit highly elaborate morphologies (a and b). AMF-R 
labels predominantly smooth tubules (c and e) but also some tubules which are partially coated with ribosomes (d). AMF-R also labels 
vesicular structures (t" and g) as well as the plasma membrane including uncoated surface invaginations (a and f).  The nucleus, plasma 
membrane (PM), mitochondria (M), and rough endoplasmic reticulum (PER) are indicated. Bars, 0.2 txm. Figure 6. AMF-R tubules do not colocalize with the calnexin-labeled rough endoplasmic reticulum. MDCK cells left untreated (a and 
b) or treated with 100/~g/ml cycloheximide  for 14 h (c and d) were double immunofluorescently  labeled for AMF-R (a and c) and ealnexin 
(b and d). Cells were incubated with Ringer's solution for 15 rain at 37"C before cold methanol fixation. Rarely, coloealization of AMF-R 
and ealnexin in the same tubular structure can be observed in untreated cells (arrows). Bar, 20 #m. 
to clearly distinguish AMF-R from calnexin-labeling dem- 
onstrates that this tubular organelle is not a subcompartment 
of the rough endoplasmic reticulum. 
Cytoskeletal Interactions of  AMF-R Tubules 
The AMF-R tubule is therefore a tubular membranous com- 
partment which can be distinguished from early endosomes, 
lysosomes, the Golgi apparatus, and the rough endoplasmic 
reticulum.  Its tubular  morphology, observed both by im- 
munofluorescence and electron microscopy, is highly sug- 
gestive of an interaction with the cellular cytoskeleton. 
In polarized epithelial cells, actin fibers are oriented cir- 
cumferentially around the cell periphery, compared to the 
actin cytoskeleton of fibroblasts, in which actin stress fibers 
are oriented the long of the cell parallel to the direction of 
cell movement (Takeuchi, 1987). This is observable even in 
the sparsely plated highly spread MDCK cells used in this 
study in which the actin fibers exhibit a circumferential dis- 
tribution around the cell periphery (Fig.  7  b).  Disruption 
of the  actin  cytoskeleton by cytochalasin D  treatment of 
MDCK cells did not disrupt AMF-R tubule morphology, but 
rather resulted in the increased elongation and extension of 
labeled tubules to the cell periphery (Fig. 7 c). Cytochalasin 
D treatment of MDCK cells induced the formation of cellu- 
lar  extensions  containing  individual  microtubules  which 
coincided with tubular AMF-R labeling (Fig. 8). Similarly, 
in untreated cells, AMF-R tubules codistribute and exhibit 
a colinearity with microtubules, however, the dense microtu- 
bule staining makes it impossible to identify the association 
of AMF-R tubules with individual microtubules (see Fig. 9, 
a  and b). These results suggest that, while not necessary to 
maintain AMF-R tubule morphology, the actin cytoskeleton 
may regulate the elongation and extension of  AMF-R tubules 
along microtubules to the cell periphery. 
To better study the effect of microtubule disruption on 
AMF-R tubule morphology, we treated MDCK cells with the 
microtubule disrupting drug nocodazole in Ringer's solution 
(Fig.  9).  Preincubation in Ringer's solution favors the for- 
marion of more elongated tubules  such that the effects of 
microtubule disrupting drugs were better observed. After a 
15-rain preincubation at 37°C in Ringer's solution, MDCK 
cells were treated with 20/zM nocodazole for 30 rain at 4°C, 
and then with nocodazole at 370C to disrupt the microtubule 
integrity of the cells. Loss of microtubule integrity was as- 
sociated with the loss of  the peripheral orientation of AMF-R 
tubules and the formation of vesicles and shorter unoriented 
The Journal of Cell Biology, Volume  129, 1995  466 Figure 7. Disruption of the actin cytoskeleton of MDCK ceils induces the elongation of AMF-R tubules. MDCK ceils were either left 
untreated (a and b) or treated with 0.5 t~g/ml cytochalasin D for 2 h at 37°C (c and d) to disrupt the actin cytoskeleton. AMF-R labeling 
was revealed with FITC-conjugated anti-rat secondary antibodies (a and c) and actin with rhodamine-conjugated phalloidin (b and d). 
Bar, 20 ~rn. 
tubules (Fig. 9, c and d). Nocodazole treatment at 4°C fol- 
lowed by warming to 37°C in the presence of  the microtubule 
stabilizing drug taxol induced the formation of short micro- 
tubule fibers and a loss of the oriented tubular morphology 
of AMF-R-labeled tubules (Fig. 9, e and f). Interestingly, 
microtubule disruption is associated with the loss of the lin- 
ear morphology of AMF-R  tubules  and  the  formation of 
"curly" tubules. This is far more evident in the taxol-treated 
cells in which tubule length was maintained, although not 
linearly.  The  results  obtained  with  nocodazole and  taxol 
clearly  indicate  that  the  linear  extension  and  peripheral 
cellular orientation of AMF-R tubules  is  microtubule de- 
pendent and identifies the AMF-R tubule as a microtubule- 
associated  organdie.  The  actin  and  microtubule  cyto- 
skeletons  may  coordinately  interact  to  regulate  AMF-R 
tubule morphology and extension to the cell periphery. 
Discussion 
The autocrine motility factor receptor, AMF-R, is expressed 
on the cell surface, where it functions as a motility factor 
receptor, as well as intracellularly within elongated tubules 
(Nabi et al.,  1992). We show here that AMF-R tubules are 
Triton  X-100  extractable  and  after  cell  homogenization 
AMF-R is localized to a  100,000-g membrane fraction. By 
immunoelectron microscopy, AMF-R is localized predomi- 
nantly to smooth membrane tubules and vesicles with an 
outer diameter which varies from 50-250 nm. To a lesser ex- 
tent, AMF-R is localized to the plasma membrane and the 
rough endoplasmic reticulum. These results are consistent 
with the plasma membrane localization of AMF-R as well 
as its localization to an intracellular membranous tubular or- 
ganelle. After disruption of the actin cytoskeleton of MDCK 
cells, AMF-R tubules extended into peripheral cellular ex- 
tensions where they exhibited a highly elongated morphol- 
ogy and can be observed to coalign with microtubules. Dis- 
ruption  of  the  microtubule  cytoskeleton  by  nocodazole 
treatment or its modulation by sequential nocodazole and 
taxol  treatment  results  in  the  loss of the  extended linear 
morphology and peripheral orientation of AMF-R tubules. 
AMF-R  is  therefore a  marker  for a  membranous  tubular 
compartment whose morphology can be regulated by modu- 
lation of the microtubule and actin cytoskeletons. 
By immunofluorescence microscopy, AMF-R tubules do 
Benlimame et al.  Tubular Localization  of AMF-R  467 Figure 8. AMF-R  tubules are associated with individual microtu- 
bules. MDCK cells treated with 0.5 #g/ml cytochalasin D were la- 
beled for AMF-R (a) and tubulin (b) and a peripheral region con- 
taining cellular extensions was enlarged to show the association of 
AMF-R vesicles with individual microtubules. The arrowheads re- 
veal a distinctive motif in which AMF-R tubules can be seen to 
directly coincide with single microtubules. Bar, 10 #m. 
not colocalize with transferrin receptor-labeled early endo- 
somes nor with BFA-induced tubules connecting the TGN 
and early endosomes. The diameter of AMF-R tubules is 
larger (50-250 rim) than tubular endosomes labeled by fluid 
phase  or transferrin endocytosis (30-60  run)  (Tooze  and 
Hollinshead, 1991; Hopkins et al.,  1994).  We also do not 
observe  colocalization of perinuclear  AMF-R  label  with 
the  Golgi  apparatus  labeled  with an  antibody to  /3-COP 
(Donaldson  et  al.,  1990).  Tubular  lysosomes have  been 
defined as lysosomal based on the presence of  lysosomal acid 
phosphatase  and  the  lysosomal  membrane  glycoprotein, 
lgpl20  (Swanson et al.,  1987; Luo and Robinson,  1992; 
Racoosin and Swanson,  1993).  However,  AMF-R tubules 
are clearly distinguished from lysosomes labeled with the 
lysosomal membrane glycoprotein LAMP-2 (Nabi and Rod- 
riguez-Boulan, 1993) by double immunofluorescent  labeling 
as well as by the ability to separate AMF-R from LAMP-2- 
containing  lysosomes by  differential  centrifugation.  The 
variable size of AMF-R tubules (50-250 nm in diameter) is 
similar but not equivalent to that observed for the tubular 
lysosome  (70-100  nm)  (Phaire-Washington et  al.,  1980; 
Swanson et al.,  1987; Araki et al.,  1993).  A tubular mor- 
phology similar to that described for the AMF-R tubule has 
been described for the basal lysosome in exocrine acinar 
cells (Oliver,  1983) and for the snake-like tubule in the exo- 
crine pancreas (Beaudoin et al.,  1985).  Interestingly, these 
similar tubular organelles are labeled cytochemicaUy by tri- 
metaphosphatase and 13-NADPase reactions but not by acid 
phosphatase reactions. As we observe for the AMF-R tubule, 
the basal lysosome appears to be closely related to the endo- 
plasmic reticulum (Oliver,  1983).  The absence of an acid 
phosphatase reaction for these tubules of exocrine cells sup- 
ports their identity with the AMF-R tubule as a similar non- 
lysosomal tubular organelle. 
The smooth AMF-R-labeled tubules can be distinguished 
morphologically from ribosome-studded tubules of the rough 
endoplasmic reticulum by their more elaborate morphology 
with evident membrane infoldings (Fig. 5, a  and b).  How- 
ever, AMF-R does label rough tubules and AMF-R tubules 
can be detected which contain both smooth and rough mem- 
branes (Table I; Fig. 5 d).  The endoplasmic reticulum la- 
beled in living cells reveals a highly interconnected tubular 
network consisting of linear tubules, a polygonal reticulum 
and triple junctions (Terasaki et al.,  1986;  Lee and Chen, 
1988; Lee et al., 1989). While isolated tubules of the endo- 
plasmic reticulum labeled fluorescently with DiOC6 resem- 
ble  AMF-R  tubules  (Terasaki  et  al.,  1986),  we  do  not 
observe an interconnected tubular network labeled by anti- 
bodies to AMF-R. The AMF-R tubule is clearly not a sub- 
compartment of  the rough endoplasmic reticulum as AMF-R 
tubular labeling can be distinguished from that of calnexin. 
Furthermore, AMF-R tubule distribution is resistant to cy- 
cloheximide treatment indicating that AMF-R is  a  stable 
constituent of this tubule which should not be considered a 
biosynthetic organelle. It is possible that the AMF-R tubule 
is related to smooth endoplasmic reticulum, an organelle as- 
sociated with lipid metabolizing cells that has been identified 
morphologically in liver and other tissues (Fawcett,  1981). 
Further definition of the relationship of the AMF-R tubule 
and the endoplasmic reticulum should prove interesting. 
Extension to the cell periphery of the endoplasmic reticu- 
lum and tubular lysosome is microtubule dependent (Ter- 
asaki et al.,  1986; Swanson et al.,  1987; Lee et al.,  1989; 
Hollenbeck and Swanson, 1990).  Similar to these two tubu- 
lar organelles, after nocodazole treatment and loss of mi- 
crotubule integrity, AMF-R tubules are shorter and show 
a  distinct loss of orientation towards the periphery of the 
cell. As described for the endoplasmic reticulum (Lee et al., 
1989),  the linear extension and peripheral  orientation of 
AMF-R tubules was not supported by short taxol-stabilized 
microtubules and  AMF-R  tubule morphology was  main- 
tained, even enhanced, after actin cytoskeleton disruption. 
The Journal of Cell Biology, Volume  129, 1995  468 Figure 9.  Linear extension and peripheral  orientation  of AMF-R tubules is microtubule dependent.  MDCK cells were preincubated  in 
Ringer's solution for 15 min (a and b) or incubated with 20 ttM nocodazole at 4°C before warming to 37°C in the continued presence 
of nocodazole (c and d) or in the presence of 10/zM taxol (e and f). Loss of microtubule integrity due to nocodazole treatment and the 
formation of  short taxol stabilized mierotubule fibers are both associated with a similar loss of  the linear extension and peripheral orientation 
of AMF-R tubules.  Bar, 20 ~trn. 
After cytoplasmic acidification, both the AMF-R tubule and 
tubular lysosome lose their tubular morphology and  form 
vesicles which move to the periphery of the cell (Heuser, 
1989; Nabi et al., 1992). These observations suggest that the 
AMF-R tubule is related to this endocytic organelle and that 
the rapid intracellular movement of these organelles occurs 
along microtubules (Heuser,  1989).  The role of kinesin in 
tubular lysosome extension to the cell periphery was demon- 
strated by the inhibitory effect of microinjected anti-kinesin 
antibodies, similar to that of nocodazole treatment (Hollen- 
Benlimame et al.  Tubular Localization of AMF-R  469 beck and Swanson,  1990). Our results suggest, as described 
for the endoplasmic reticulum and the tubular lysosome, that 
the extension of the AMF-R tubule to the cell periphery is 
mediated by the microtubule cytoskeleton. 
We propose that the AMF-R tubule constitutes, along with 
the tubular lysosome and endoplasmic reticulum, a member 
of a  family  of microtubule-associated  tubular organelles. 
These organdies may act in various cellular functions to tar- 
get cellular components  to peripheral regions of the cell. 
Differential morphology and extension throughout the cyto- 
plasm of the endoplasmic  reticulum may enhance its sur- 
face area and increase  the efficiency  of protein  synthesis 
(Rajasekaran et al., 1993). The tubular lysosome or tubular 
compartment of the macrophage may serve to deliver lyso- 
somal  components  to  newly  internalized  phagosomes  or 
pinosomes (Knapp and Swanson,  1990; Rabinowitz et al., 
1992; Racoosin and Swanson, 1993). The identity of AMF-R 
as a receptor for a motility factor with a defined role in cell 
motility and tumor metastasis implicates the AMF-R tubule 
in the motile process. 
Forward cell locomotion is associated  with cytoskeletal 
force-generating mechanisms, insertion of membrane at the 
leading edge, and the coordinate establishment and disrup- 
tion of cell-substrate adhesive contacts (Singer and Kupfer, 
1986). Disruption of microtubules by specific drugs has long 
been known to inhibit cell movement (Vasiliev et al., 1970; 
Gail and Boone, 1971; Goldman,  1971). Newly synthesized 
VSV G protein has been shown to be targeted to the leading 
edge of motile fibroblasts (Bergnmma et al., 1983). Nocoda- 
zole treatment disrupts the polarity of G protein insertion 
into the plasma membrane implicating microtubules in the 
determination of  the directionality of  pseudopodial extension 
(Rogalski et al., 1984). Extension of microtubules into neu- 
ronal growth cones after cytochalasin D treatment suggests 
that the actin cytoskeleton network can restrict microtubule 
extension  into  peripberal larnella (Forscher  and  Smith, 
1988). Directed microtubule extension towards growth cone 
target interactions are apparently guided by localized F-actin 
assembly  (Lin and Forscher, 1993).  The increased elonga- 
tion and extension of AMF-R tubules to the call periphery 
after cytoehalasin D treatment of MDCK cells may reflect 
a restrictive role for the actin cytoskeleton on the extension 
of microtubules and AMF-R tubules to the cell periphery. 
The AMF-R tubule is a candidate for a motility specific com- 
partment targeted along microtubules to the leading edge of 
motile cells. AMF-R endocytosis and intracellular targeting 
to this tubular organelle might thus be involved in the func- 
tion of AMF-R as a motility factor receptor. However, the 
AMF-R tubule is apparently not equivalent to the transferrin 
receptor labeled tubular endosome  targeted to the leading 
edge of migrating fibroblasts (Hopkins et al.,  1994). 
Autocrine motility factor receptor is described here as a 
marker for a distinct microtubule-associated tubular mem- 
branous organelle. The AMF-R tubule can be distinguished 
from early endosomes,  lysosomes, the endoplasmic reticu- 
lum, and the Golgi apparatus identified by specific markers. 
The AMF-R tubule is a smooth membranous structure which 
can form extended tubular networks. The availability of a 
marker for this tubular organelle will allow the further char- 
acterization of the nature of this organdie as well as the de- 
termination of its role in cell motility. 
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